Infinity Stock Performance

INFI -  USA Stock  

USD 0.75  0.15  25.00%

The company retains a Market Volatility (i.e., Beta) of 2.3529, which attests to a somewhat significant risk relative to the market. Let's try to break down what Infinity's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Infinity Pharmaceuti will likely underperform. Even though it is essential to pay attention to Infinity Pharmaceuti current price history, it is always good to be careful when utilizing equity current price movements. Our philosophy towards determining any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Infinity Pharmaceuti exposes twenty-seven different technical indicators, which can help you to evaluate its performance. Infinity Pharmaceuti has an expected return of -0.32%. Please be advised to check out Infinity Pharmaceuti information ratio, downside variance, day median price, as well as the relationship between the treynor ratio and kurtosis to decide if Infinity Pharmaceuti performance from the past will be repeated at some point in the near future.
  
Refresh
Infinity Performance
0 of 100
Over the last 90 days Infinity Pharmaceuti has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in June 2022. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more

Infinity Price Channel

Quick Ratio6.07
Fifty Two Week Low0.4600
Target High Price11.00
Fifty Two Week High3.8900
Target Low Price3.50

Infinity Pharmaceuti Relative Risk vs. Return Landscape

If you would invest  110.00  in Infinity Pharmaceuti on February 27, 2022 and sell it today you would lose (35.00)  from holding Infinity Pharmaceuti or give up 31.82% of portfolio value over 90 days. Infinity Pharmaceuti is currently does not generate positive expected returns and assumes 7.4046% risk (volatility on return distribution) over the 90 days horizon. In different words, 63% of stocks are less volatile than Infinity, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Infinity Pharmaceuti is expected to under-perform the market. In addition to that, the company is 5.51 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.02 per unit of volatility.

Infinity Pharmaceuti Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Infinity Pharmaceuti's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Infinity Pharmaceuti, and traders can use it to determine the average amount a Infinity Pharmaceuti's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0427

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsINFI
Estimated Market Risk
 7.4
  actual daily
 
 63 %
of total potential
 
6363
Expected Return
 -0.32
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.04
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Infinity Pharmaceuti is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Infinity Pharmaceuti by adding it to a well-diversified portfolio.

About Infinity Pharmaceuti Performance

To evaluate Infinity Pharmaceuti Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Infinity Pharmaceuti generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Infinity Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Infinity Pharmaceuti stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Infinity's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(174.51) (179.10) 
Return on Average Assets(0.46) (0.49) 
Return on Average Equity(1.23) (1.26) 
Return on Invested Capital 8.34  9.00 
Return on Sales(24.26) (24.90) 
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Things to note about Infinity Pharmaceuti

Checking the ongoing alerts about Infinity Pharmaceuti for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Infinity Pharmaceuti help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Infinity Pharmaceuti Alerts

Equity Alerts and Improvement Suggestions

Infinity Pharmaceuti generated a negative expected return over the last 90 days
Infinity Pharmaceuti has high historical volatility and very poor performance
Infinity Pharmaceuti has some characteristics of a very speculative penny stock
Infinity Pharmaceuti was previously known as INFINITY PHARMACEUTICALS INC and was traded on NASDAQ Exchange under the symbol DPII.
The company reported the previous year's revenue of 1.86 M. Net Loss for the year was (45.26 M) with loss before overhead, payroll, taxes, and interest of (30.91 M).
Infinity Pharmaceuti currently holds about 80.73 M in cash with (40.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Infinity Pharmaceuti has a frail financial position based on the latest SEC disclosures
Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.